Bristol-myers squibb stock.

Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com.17.04M (132.72% of Avg) Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.Bristol-Myers Squibb is forecast to grow earnings and revenue by 11.4% and 0.1% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 46.2% in 3 years.Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com . Find the dividend history information for BMY stock including payable date, record date, amount and dividend type from 1970 until present.

Get the latest Bristol-Myers Squibb Co (BMYS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

In the latest trading session, Bristol Myers Squibb (BMY) closed at $65.04, marking a -0.4% move from the previous day. This change was narrower than the S&P 500's daily loss of 0.77%.Bristol-Myers Squibb has no non-voting common equity. At February 1, 2013, there were 1,637,354,662 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Proxy Statement for the registrant’s Annual Meeting of Stockholders to be held May 1, 2013 are incorporated by reference into Part III of this Annual ...

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [1] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com. Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com.Bristol-Myers Squibb Company is undervalued; there is no denying that at 7X earnings. It is priced for -3% long-term growth, and analysts expect flat growth for the foreseeable future.Bristol-Myers Squibb reported $2.44B in Stock for its fiscal quarter ending in September of 2023. Data for Bristol-Myers Squibb | BMY - Stock including ...

Going by our Bristol Myers Squibb Valuation of $79 per share, based on $7.52 expected adjusted EPS and around 10x P/E multiple for 2021, there is an upside potential of 45% from its current levels ...

Summary. I expected Bristol-Myers Squibb Company stock to keep rising in value through 2023 and perhaps reach triple figures. Instead, the share price has fallen 5% this year as inflationary ...

Bristol Myers Squibb Co. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:59 p.m. EST Delayed quote $ 50.17 0.07 0.14% After Hours Volume: 403.99K Advanced Charting...Bristol Myers' lung cancer drug candidate could be just months away from U.S. Food and Drug Administration approval. Last month, Bristol Myers Squibb ( BMY -0.20%) shared that its locally advanced ...Feb 17, 2023 · It's a new day at Bristol Myers Squibb (), according to a company executive.But BMY stock remains under pressure ahead of a patent cliff threatening $200 billion in pharma sales by 2030. X. Over ... Help paying for your medicines. If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Bristol Myers Squibb is a global biopharmaceutical company …Quick links. At Bristol Myers Squibb, we work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to …

The next Bristol-Myers Squibb Co. dividend is expected to go ex in 1 month and to be paid in 2 months. The previous Bristol-Myers Squibb Co. dividend was 57c and it went ex 2 months ago and it was paid 1 month ago. There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.4.Under the terms of the merger, Celgene shareholders received for each share, 1.00 share of Bristol-Myers Squibb common stock, $50.00 in cash without interest and one tradeable Contingent Value Right (CVR), which will entitle the holder to receive a payment of $9.00 in cash if certain future regulatory milestones are achieved.Bristol-Myers Squibb Company (BMY) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium dividend score.Recent developments: Bristol-Myers Squibb's stock hit a 52-week low after disappointing Q2 results. Generic competition impacted earnings, with key drugs facing competition by 2028.Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Bristol-Myers Squibb Company stock was issued.Bristol-Myers Squibb Company (BMY) dividend growth history: By month or year, chart. Dividend history includes: Declare date, ex-div, record, pay, frequency, amount.Bristol Myers agrees to pay Avidity $60 million in cash and also will purchase about $40 million of Avidity common stock at $7.88 a share. ... deal with Bristol Myers Squibb. Avidity stock was ...

1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the telephone numbers above. To contact in writing: EQ Shareowner Services. 1110 Centre Pointe Curve, Suite 101.According to 18 analysts, the average rating for BMY stock is "Buy." The 12-month stock price forecast is $64.65, which is an increase of 27.83% from the latest ...

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [1] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the telephone numbers above. To contact in writing: EQ Shareowner Services. 1110 Centre Pointe Curve, Suite 101.27 thg 9, 2023 ... Returning to the pre-inflation shock level of over $80 means that BMY stock will have to gain more than 35% from here, and we think it will ...Bristol-Myers Squibb has no non-voting common equity. At February 1, 2013, there were 1,637,354,662 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Proxy Statement for the registrant’s Annual Meeting of Stockholders to be held May 1, 2013 are incorporated by reference into Part III of this Annual ...Bristol Myers Squibb stock recently dropped to a multiyear low, and the pharmaceutical company’s lead independent director bought shares on the open market …Compared to the current market price of 49.835 USD , Bristol-Myers Squibb Co is Undervalued by 45%. ALPHA SPREAD. Join 87,600+ value investors using Alpha Spread. Create a free account. or see our plans & pricing. Bristol-Myers Squibb Co (NYSE:BMY) Intrinsic Valuation. Check if BMY is overvalued or undervalued under the bear, base, and …

Find the latest stock quote, chart, news and investor resources for Bristol Myers Squibb (BMY), a global biopharmaceutical company. Learn about the company's financial …

Track Bristol-Myers Squibb Co. (BMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Find the latest analyst research for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com.Description. Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U ...Executive severance benefits. Patients & Caregivers. UK-CA Slavery and Human Trafficking Statement (PDF) Forward-Looking Statement. Worldwide Locations. Contact Us. Learn more about Bristol Myers Squibb's policies on executive compensation, stock option repricing, stockholder rights, compliance violations and severance benefits.Bristol-Myers Squibb Co’s stock is NA in 2023, NA in the previous five trading days and down 37.41% in the past year. Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.5. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% net profit margin. Year-over-year quarterly sales growth most recently ... Bristol-Myers Squibb stock has received a consensus rating of hold. The average rating score is and is based on 20 buy ratings, 21 hold ratings, and 11 sell ratings. What was the 52-week low for...Last month, Bristol Myers Squibb ( BMY 0.69%) shared that its locally advanced or metastatic non-small cell lung cancer (NSCLC) drug candidate repotrectinib was accepted for priority review by the ...Summary. Bristol-Myers Squibb Company is facing challenges due to the loss of exclusivity of its drug Revlimid and the need for new product growth. The company made a transformative deal with the ...Stock Exchange NYSE Ticker Symbol BMY Full Company Profile Financial Performance In 2022, BMY's revenue was $46.16 billion, a decrease of -0.49% …Bristol-Myers Squibb's stock is down 40% despite a market increase of 20%. Read here why we think BMY may be undervalued.Bristol-Myers Squibb Co’s stock is NA in 2023, NA in the previous five trading days and down 37.41% in the past year. Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.5. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% net profit margin. Year-over-year quarterly sales growth most recently ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. Nov 22, 2023 · According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ...

To that point, Bristol Myers stock trades at $65 per share and just 8.2X forward earnings which is nicely below its industry average of 18X and the S&P 500’s 17.9X. Similarly, CVS trades at 8.7X ...Real-Time News, Market Data and Stock Quote for Bristol-Myers Squibb.BMY) stock’s latest price update. The stock of Bristol-Myers Squibb Co. (NYSE: BMY) has increased by 1.46 when compared to last closing price of 49.38.Despite this, the company has seen a gain of 0.68% in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-29 that The FDA has undertaken an …Recent developments: Bristol-Myers Squibb's stock hit a 52-week low after disappointing Q2 results. Generic competition impacted earnings, with key drugs facing competition by 2028.Instagram:https://instagram. what is better than coinbasebest trading brokers for forexjohn deere share pricefinancial advisor orange ca Executive severance benefits. Patients & Caregivers. UK-CA Slavery and Human Trafficking Statement (PDF) Forward-Looking Statement. Worldwide Locations. Contact Us. Learn more about Bristol Myers Squibb's policies on executive compensation, stock option repricing, stockholder rights, compliance violations and severance benefits. fdig etfvision insurance cost per month Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.View Bristol Myers Squibb Company BMY investment & stock information. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. airsculpt machine Stock split history for Bristol-Myers Squibb (BMY) Bristol-Myers Squibb stock (symbol: BMY) underwent a total of 6 stock splits. The most recent stock split occured on August 7th, 2001. One BMY share bought prior to May 31st, 1977 would equal to 33.621320960687 BMY shares today. Stock split list. DateBristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.1 Day BMY 1.35% DJIA 1.47% S&P 500 0.38% Health Care/Life Sciences 0.38% Overview to Download a Spreadsheet DATE OPEN HIGH